In order to develop a deeper understanding of the mechanism of action for adiponectin in pancreatic cancer progression, we investigated the effect of its synthetic agonist, AdipoRon, on PDAC cellular metabolism. The gene discussed is ADIPOQ; the disease is pancreatic neoplasm.